Delving into the Latest Updates on Interferon alpha-2b(Shandong Kexing Bioproducts) with Synapse

Overview

Basic Info

Drug Type

Interferons

Synonyms-

Target

IFNAR

Action

agonists, stimulants

Mechanism

IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants

Therapeutic Areas

Infectious DiseasesMouth and Tooth DiseasesSkin and Musculoskeletal Diseases+ [1]

Active Indication

Herpes GenitalisHerpes LabialisUterine Cervicitis

Inactive Indication-

Originator Organization

Shandong Kexing Bioproducts Co., Ltd.

Active Organization

Shandong Kexing Bioproducts Co., Ltd.

Inactive Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

1) To evaluate the safety, tolerability and immunogenicity of single and multiple administrations of human interferon α2b spray in healthy Chinese subjects and determine the maximum tolerated dose. 2) To investigate the pharmacokinetic characteristics of single and multiple administrations of human interferon α2b spray in healthy Chinese subjects.

Start Date02 Dec 2022

Sponsor / Collaborator

Shenzhen Kexing Pharmaceutical Co., Ltd.

[+1]

ISRCTN46751362

/ CompletedNot Applicable

A European randomised multicentre study of interferon alpha-2b versus no treatment after intensive therapy and Autologous hematopoeitic Stem Cell Transplantation (ASCT) for relapsing lymphoma patients

Start Date01 Jan 1999

Sponsor / Collaborator

Schering-Plough Ltd.

100 Clinical Results associated with Interferon alpha-2b(Shandong Kexing Bioproducts)

Login to view more data

100 Translational Medicine associated with Interferon alpha-2b(Shandong Kexing Bioproducts)

Login to view more data

100 Patents (Medical) associated with Interferon alpha-2b(Shandong Kexing Bioproducts)

Login to view more data

100 Deals associated with Interferon alpha-2b(Shandong Kexing Bioproducts)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Herpes Genitalis	Phase 1	China	Shandong Kexing Bioproducts Co., Ltd.	02 Dec 2022
Herpes Labialis	Phase 1	China	Shandong Kexing Bioproducts Co., Ltd.	02 Dec 2022
Uterine Cervicitis	IND Approval	China	Shandong Kexing Bioproducts Co., Ltd.	14 Oct 2022

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Study	Phase	Population	Analyzed Enrollment	Group	Results	Evaluation	Publication Date


2018 ARVO Annual Meeting (ARVO2018)	Not Applicable	Neoplasms Adjuvant	39	Topical interferon alpha-2b	(bldcdaqkoc) = umgefxjumi oshrhalrpk (kljpbxgsur ) View more	Positive	01 Jul 2018
				Subconjunctival interferon alpha-2b	(bldcdaqkoc) = ukdhprjjrv oshrhalrpk (kljpbxgsur ) View more

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.

login

or

view full example data

Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.

login

or

view full example data

Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.

login

or

view full example data

Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

login

or

view full example data